Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No adverse media involving Cinapsis found in HSH's search of the last 24 months.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Cinapsis found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Clinical advice-and-guidance communication software supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract delivery, go-lives, terminations and disputes.
Jun 2025: Mid Cheshire Hospitals NHS FT awarded Cinapsis (Monmedical Ltd) a £26,000 contract for dermatology referral and advice and guidance covering it and East Cheshire NHS Trust. Apr 2026: the company reported 45,891 patients supported in a year across 20+ services in Gloucestershire.